MedTrace Logo

Clinical Data Collection of Myopic Patients After PTK-PRK With CZM MEL 90 Excimer Laser

NCT06996353 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-01-09

No results posted yet for this study

Summary

The objective of the clinical investigation presented to is to verify predictions of post-operative PTK-PRK refractive outcome made by the EpiMaster application software by comparing these to post-operative clinical data after routine PTK-PRK treatments.

Conditions

  • Refractive Errors

Interventions

PROCEDURE

PTK-PRK refractive treatment

The PTK-PRK refractive treatment will be done according to routine clinical practice.

Sponsors & Collaborators

  • Optana GmbH

    collaborator OTHER

  • London Vision Clinic

    lead OTHER

Principal Investigators

  • Dan Z Reinstein, MD · London Vision Clinic Ltd., London, United Kingdom

  • Sheetal Brar, MD · Pro Sight Eye Hospital, Chandigarh, India

  • Aadithreya Varman, MD · Uma Eye Clinic, Chennai, India

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-26
Primary Completion
2026-11-30
Completion
2027-06-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06996353 on ClinicalTrials.gov